About Arvind Kush
Form D filings for Candid Therapeutics in 2024 list Arvind Kush as executive officer.
Arvind Kush first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Arvind Kush in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Arvind Kush works with at each company, as listed on that company's latest Form D.
Candid Therapeutics, Inc. · Form D, Sep 13, 2024
JD
Jeffrey Tong, Ph.D.
Director
TD
Timothy Lu, M.D.
Executive officer
KD
Kenneth Song, M.D.
President and CEO, director
AD
Aaron Royston, M.D.
Director
BD
Bernie Huyghe, Ph.D.
Executive officer
MD
Michael Rome, M.D.
Director